1. Home
  2. INVE vs ANVS Comparison

INVE vs ANVS Comparison

Compare INVE & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVE
  • ANVS
  • Stock Information
  • Founded
  • INVE 1990
  • ANVS 2008
  • Country
  • INVE United States
  • ANVS United States
  • Employees
  • INVE N/A
  • ANVS N/A
  • Industry
  • INVE Computer peripheral equipment
  • ANVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVE Technology
  • ANVS Health Care
  • Exchange
  • INVE Nasdaq
  • ANVS Nasdaq
  • Market Cap
  • INVE 74.2M
  • ANVS 54.6M
  • IPO Year
  • INVE 1997
  • ANVS 2020
  • Fundamental
  • Price
  • INVE $3.26
  • ANVS $2.18
  • Analyst Decision
  • INVE Strong Buy
  • ANVS Strong Buy
  • Analyst Count
  • INVE 3
  • ANVS 5
  • Target Price
  • INVE $6.50
  • ANVS $30.25
  • AVG Volume (30 Days)
  • INVE 52.7K
  • ANVS 616.9K
  • Earning Date
  • INVE 08-07-2025
  • ANVS 08-14-2025
  • Dividend Yield
  • INVE N/A
  • ANVS N/A
  • EPS Growth
  • INVE N/A
  • ANVS N/A
  • EPS
  • INVE 3.12
  • ANVS N/A
  • Revenue
  • INVE $25,239,000.00
  • ANVS N/A
  • Revenue This Year
  • INVE N/A
  • ANVS N/A
  • Revenue Next Year
  • INVE $9.00
  • ANVS N/A
  • P/E Ratio
  • INVE $1.05
  • ANVS N/A
  • Revenue Growth
  • INVE N/A
  • ANVS N/A
  • 52 Week Low
  • INVE $2.86
  • ANVS $1.11
  • 52 Week High
  • INVE $4.35
  • ANVS $17.88
  • Technical
  • Relative Strength Index (RSI)
  • INVE 48.50
  • ANVS 43.14
  • Support Level
  • INVE $3.10
  • ANVS $2.52
  • Resistance Level
  • INVE $3.25
  • ANVS $3.18
  • Average True Range (ATR)
  • INVE 0.11
  • ANVS 0.31
  • MACD
  • INVE 0.00
  • ANVS -0.10
  • Stochastic Oscillator
  • INVE 38.46
  • ANVS 5.38

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Share on Social Networks: